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Abstract 
Background: Tuberculosis (TB), is caused by the bacteria, Mycobacterium tuberculosis and 
its a threat to humans since centuries. Depending on the type of TB, its treatment can last for 
6-24 months which is a major cause for patients non-compliance and treatment failure. Many 
adverse effects are associated with the currently available TB medicines, and there has been 
no new anti-tuberculosis drug on the market for more than 50 year, as the drug development 
is very lengthy and budget consuming process.Development of the biocompatible nano drug 
delivery systems with the ability to minimize the side effects of the drugs, protection of the 
drug from enzymatic degradation. And most importantly the drug delivery systems which can 
deliver the drug at target site would increase the therapeutic efficacy. Nanovehicles with their 
tendency to release the drug in a sustained manner would result in the bioavalibilty of the 
drugs in the body for a longer period of time and this would reduce the dosing frequency in 
drug administration. The biocompatible nanovehicles with the properties like sustained 
release of drug of the target site, protection of the drug from physio-chemical degradation, 
reduction in dosing frequency, and prolong bioavailability of drug in the body would result in 
the shortening of the treatment duration. All of these factors would improve the patient 
compliance with chemotherapy of TB.Result: An anti-tuberculosis drug, 4-amino salicylic 
acid (4-ASA) was successfully intercalated into the interlamellae of zinc layered hydroxide 
(ZLH) via direct reaction with zinc oxide suspension. The X-ray diffraction patterns and 
FTIR analyses indicate that the molecule was successfully intercalated into the ZLH 
interlayer space with an average basal spacing of 24 Å. Furthermore, TGA and DTG results 
show that the drug 4-ASA is stabilized in the interlayers by electrostatic interaction. The 
release of 4-ASA from the nanocomposite was found to be in a sustained manner. The 
nanocomposite treated with normal 3T3 cells shows it reduces cell viability in a dose- and 
time-dependent manner.Conclusions: Sustained release formulation of the nanocomposite, 4-
ASA intercalated into zinc layered hydroxides, with its ease of preparation, sustained release 
of the active and less-toxic to the cell is a step forward for a more patient-friendly 
chemotherapy of Tuberculosis. 
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